{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T23:30:34Z","timestamp":1787614234380,"version":"build-2736575974"},"reference-count":28,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","transplantation-proceedings.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.transproceed.2016.01.079","type":"journal-article","created":{"date-parts":[[2016,8,3]],"date-time":"2016-08-03T23:46:43Z","timestamp":1470268003000},"page":"1756-1760","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Predictive Value of Hepatic and Renal Dysfunction Based on the Models for End-Stage Liver Disease in Patients With Heart Failure Evaluated for Heart Transplant"],"prefix":"10.1016","volume":"48","author":[{"given":"B.","family":"Szygu\u0142a-Jurkiewicz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Nadziakiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Zakliczynski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Szczurek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Chraponski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Zembala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Gasior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2016.01.079_bib1","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1093\/eurheartj\/ehs104","volume":"33","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.transproceed.2016.01.079_bib2","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.healun.2013.08.009","article-title":"ISHLT International Registry for Heart and Lung Transplantation\u2013into the fourth decade, from strength to strength","volume":"32","author":"Stehlik","year":"2013","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.transproceed.2016.01.079_bib3","doi-asserted-by":"crossref","first-page":"2660","DOI":"10.1161\/01.CIR.95.12.2660","article-title":"Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation","volume":"95","author":"Aaronson","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.transproceed.2016.01.079_bib4","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.amjcard.2006.05.031","article-title":"A\u00a0novel prognostic index to determine the impact of cardiac conditions and co-morbidities on one-year outcome in patients with heart failure","volume":"98","author":"Senni","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.transproceed.2016.01.079_bib5","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1161\/CIRCULATIONAHA.105.584102","article-title":"The Seattle Heart Failure Model: prediction of survival in heart failure","volume":"113","author":"Levy","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.transproceed.2016.01.079_bib6","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.healun.2007.10.016","article-title":"The Munich Score: a clinical index to predict survival in ambulatory patients with chronic heart failure in the era of new medical therapies","volume":"27","author":"Stempfle","year":"2008","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.transproceed.2016.01.079_bib7","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1161\/01.CIR.83.3.778","article-title":"Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure","volume":"83","author":"Mancini","year":"1991","journal-title":"Circulation"},{"key":"10.1016\/j.transproceed.2016.01.079_bib8","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1053\/he.2000.5852","article-title":"A\u00a0model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts","volume":"31","author":"Malinchoc","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.transproceed.2016.01.079_bib9","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/ncpgasthep0070","article-title":"Patient selection in an era of donor liver shortage: Current US policy","volume":"2","author":"Wiesner","year":"2005","journal-title":"Nat Clin Pract Gastroenterol Hepatol"},{"key":"10.1016\/j.transproceed.2016.01.079_bib10","first-page":"178","article-title":"The Model for End-Stage Liver Disease (MELD) can predict outcomes in ambulatory patients with advanced heart failure who have been referred for cardiac transplantation evaluation","volume":"11","author":"Szygu\u0142a-Jurkiewicz","year":"2014","journal-title":"Kardiochir Torakochirurgia Pol"},{"key":"10.1016\/j.transproceed.2016.01.079_bib11","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1002\/lt.20906","article-title":"MELD-XI: a rational approach to \u201csickest first\u201d liver transplantation in cirrhotic patients requiring anticoagulant therapy","volume":"13","author":"Heuman","year":"2007","journal-title":"Liver Transpl"},{"key":"10.1016\/j.transproceed.2016.01.079_bib12","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1053\/jhep.2001.22172","article-title":"A\u00a0model to predict survival in patients with end-stage liver disease","volume":"33","author":"Kammath","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.transproceed.2016.01.079_bib13","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1056\/NEJMoa0801209","article-title":"Hyponatremia and mortality among patients on the liver-transplant waiting list","volume":"359","author":"Kim","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.transproceed.2016.01.079_bib14","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1056\/NEJMoa1202299","article-title":"Warfarin and aspirin in patients with heart failure and sinus rhythm","volume":"366","author":"Homma","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.transproceed.2016.01.079_bib15","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.cardfail.2009.08.002","article-title":"Abnormal liver function in relation to hemodynamic profile in heart failure patients","volume":"16","author":"van Deursen","year":"2010","journal-title":"J\u00a0Card Fail"},{"key":"10.1016\/j.transproceed.2016.01.079_bib16","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1365-2362.2011.02573.x","article-title":"Liver dysfunction in chronic heart failure: prevalence, characteristic and prognostic significance","volume":"42","author":"Poelzl","year":"2012","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.transproceed.2016.01.079_bib17","doi-asserted-by":"crossref","first-page":"227","DOI":"10.20452\/pamw.138","article-title":"Effect of elevated bilirubin levels on the long-term outcome in patients with chronic heart failure due to hypertension","volume":"117","author":"Szygu\u0142a-Jurkiewicz","year":"2007","journal-title":"Pol Arch Med Wewn"},{"key":"10.1016\/j.transproceed.2016.01.079_bib18","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1016\/j.jacc.2012.12.056","article-title":"Hepatic dysfunction in ambulatory patients with heart failure","volume":"61","author":"Kim","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.transproceed.2016.01.079_bib19","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.healun.2012.11.026","article-title":"Risk stratification of ambulatory patients with advanced heart failure undergoing evaluation for heart transplantation","volume":"32","author":"Kato","year":"2013","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.transproceed.2016.01.079_bib20","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1161\/CIRCULATIONAHA.108.838656","article-title":"Model for End-Stage Liver Disease score predicts left ventricular assist device operative transfusion requirements, morbidity, and mortality","volume":"121","author":"Matthews","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.transproceed.2016.01.079_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0100618","article-title":"Liver dysfunction assessed by Model for End-Stage Liver Disease Excluding INR (MELD-XI) scoring system predicts adverse prognosis in heart failure","volume":"9","author":"Abe","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.transproceed.2016.01.079_bib22","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.ijcard.2014.08.052","article-title":"Prognostic impact of renal and hepatic dysfunction based on the MELD-XI score in patients with acute heart failure","volume":"167","author":"Inohara","year":"2014","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.transproceed.2016.01.079_bib23","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/0002-8703(56)90099-0","article-title":"A\u00a0study of C-reactive protein in the serum of patients with congestive heart failure","volume":"51","author":"Elser","year":"1956","journal-title":"Am Heart J"},{"key":"10.1016\/j.transproceed.2016.01.079_bib24","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1161\/01.CIR.0000159336.31613.31","article-title":"Inflammation and endothelial function: direct vascular effects of human C-reactive protein on nitric oxide bioavailability","volume":"111","author":"Clapp","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.transproceed.2016.01.079_bib25","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1161\/01.CIR.0000143073.60937.50","article-title":"Endothelial dysfunction and damage in congestive heart failure: relation of flow-mediated dilatation to circulating endothelial cells, plasma indexes of endothelial damage, and brain natriuretic peptide","volume":"110","author":"Chong","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.transproceed.2016.01.079_bib26","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.cardfail.2008.10.030","article-title":"Prognostic value of high-sensitivity C-reactive protein in heart failure: a systematic review","volume":"15","author":"Araujo","year":"2009","journal-title":"J\u00a0Card Fail"},{"key":"10.1016\/j.transproceed.2016.01.079_bib27","doi-asserted-by":"crossref","first-page":"56A","DOI":"10.1016\/j.amjcard.2007.11.024","article-title":"Amino-terminal pro-B-type natriuretic peptides and prognosis in chronic heart failure","volume":"101","author":"Masson","year":"2008","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.transproceed.2016.01.079_bib28","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1016\/j.jacc.2010.05.049","article-title":"Assessment of conventional cardiovascular risk factors and multiple biomarkers for the prediction of incident heart failure and atrial fibrillation","volume":"56","author":"Smith","year":"2010","journal-title":"J\u00a0Am Coll Cardiol"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134516003419?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134516003419?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T12:15:47Z","timestamp":1749039347000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134516003419"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["S0041134516003419"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2016.01.079","relation":{},"ISSN":["0041-1345"],"issn-type":[{"value":"0041-1345","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predictive Value of Hepatic and Renal Dysfunction Based on the Models for End-Stage Liver Disease in Patients With Heart Failure Evaluated for Heart Transplant","name":"articletitle","label":"Article Title"},{"value":"Transplantation Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transproceed.2016.01.079","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}